Scarica l'app Stockscreener
23.14
0.52%
0.155
Precedente Chiudi:
$22.98
Aprire:
$23.13
Volume 24 ore:
147.64K
Relative Volume:
0.14
Capitalizzazione di mercato:
$1.98B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
36.72
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
+0.35%
1M Prestazione:
+11.11%
6M Prestazione:
+4.91%
1 anno Prestazione:
-18.26%
Intervallo 1D:
$22.94
$23.28
Intervallo di 1 settimana:
$21.83
$23.32
Portata 52W:
$13.39
$29.65
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Confronta PGNY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.14 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
287.96 | 264.62B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
302.23 | 80.79B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.61 | 80.89B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
289.86 | 75.71B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
232.45 | 26.78B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Downgrade | Truist | Buy → Hold |
| 2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Iniziato | BTIG Research | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-08-12 | Iniziato | Barclays | Overweight |
| 2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-02 | Iniziato | Guggenheim | Buy |
| 2019-11-19 | Iniziato | Citigroup | Buy |
| 2019-11-19 | Iniziato | Goldman | Buy |
| 2019-11-19 | Iniziato | JP Morgan | Overweight |
| 2019-11-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
What drives Progyny Inc. stock priceBreakthrough financial growth - Autocar Professional
Is Progyny Inc. a good long term investmentPhenomenal trading returns - jammulinksnews.com
Progyny Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com
When (PGNY) Moves Investors should Listen - news.stocktradersdaily.com
Progyny Investors Wait For Growth To Catch Up To Hope - Finimize
Progyny Stock Gains 3.1% Amid Market Rally and Earnings OptimismNews and Statistics - IndexBox
Why Progyny (PGNY) Stock Is Up Today - Yahoo Finance
What analysts say about Progyny Inc. stockUnstoppable investment returns - Autocar Professional
Why Progyny (PGNY) Stock Is Falling Today - Yahoo Finance
Truist Securities Maintains Hold Rating on Progyny (PGNY), Raise - GuruFocus
Progyny: Truist Securities Maintains Hold, Raises PT to $27 from $24. - AInvest
Progyny (PGNY) Price Target Increased Amid Mixed Investor Sentim - GuruFocus
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com Nigeria
Where are the Opportunities in (PGNY) - news.stocktradersdaily.com
Progyny Secures $200M Credit Facility with JPMorgan - TipRanks
Progyny rises on guidance update - MSN
Progyny and Oura: A Wearable Tech Revolution in Women's Health and Its Implications for Investors - AInvest
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitori - GuruFocus
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitoring | PGNY Stock News - GuruFocus
Progyny partners with Oura for women’s health monitoring - Investing.com Australia
Progyny Partners with ?URA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause | PGNY Stock News - GuruFocus
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - The Manila Times
Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology - Quiver Quantitative
Progyny Partners with ŌURA to Empower Women and Their Care - GlobeNewswire
Truist Financial Keeps Their Hold Rating on Progyny (PGNY) - The Globe and Mail
Progyny (PGNY) Receives a Hold from Canaccord Genuity - The Globe and Mail
BTIG Keeps Their Buy Rating on Progyny (PGNY) - The Globe and Mail
Progyny upgraded to Outperform at Leerink after positive pre-announcement - MSN
Progyny Inc Stock (PGNY): Strong Growth Post Q1 Results - Value The Markets
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? - Yahoo Finance
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance By Investing.com - Investing.com South Africa
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance - Investing.com Nigeria
Leerink Partners upgrades Progyny stock rating to Outperform on improved membership activity - Investing.com Canada
Progyny (PGNY) Receives Rating Upgrade from Leerink Partners | P - GuruFocus
Sector Update: Health Care - MarketScreener
Progyny stock rises as BofA reiterates Buy rating on better-than-expected Q2 - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook By Investing.com - Investing.com South Africa
Progyny (PGNY) Expects to Surpass Q2 2025 Projections - GuruFocus
Progyny expects Q2 results above previous forecast; shares gain - TradingView
Under the Radar: Hunting Smart in the Alleyway of Value and Growth - Benzinga
Progyny stock (PGNY) rises: what’s going on with Progyny Inc? - Markets.com
Progyny Expects Q2 Results 'Slightly Above' Guidance, Enters $200 Million Revolver; Shares Rise - MarketScreener
Progyny stock rises on guidance update (PGNY:NASDAQ) - Seeking Alpha
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
1.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):